Immunitybio to host key opinion leader and investor meeting to provide updates on clinical programs and anktiva commercial launch

Culver city, calif.--(business wire)--immunitybio, inc. (nasdaq: ibrx), a leading immunotherapy company, today announced details about its investor day program to be held on tuesday, april 15, 2025, at 10:00 am pdt. the program will include an in-depth update on the company's business operations, u.s. and global regulatory advances of its clinical-stage products, with fireside chats hosted by dr. patrick soon-shiong and key opinion leaders involved in the company's research programs. the discus.
IBRX Ratings Summary
IBRX Quant Ranking